- Home
- PULM vs KITT Comparison
PULM vs KITT Comparison
Compare PULM & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- KITT
- Stock Information
- Founded
- PULM 2003
- KITT 2014
- Country
- PULM United States
- KITT United States
- Employees
- PULM N/A
- KITT N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- KITT Industrial Machinery/Components
- Sector
- PULM Health Care
- KITT Industrials
- Exchange
- PULM Nasdaq
- KITT Nasdaq
- Market Cap
- PULM 33.2M
- KITT 38.8M
- IPO Year
- PULM N/A
- KITT N/A
- Fundamental
- Price
- PULM $7.43
- KITT $0.94
- Analyst Decision
- PULM
- KITT
- Analyst Count
- PULM 0
- KITT 0
- Target Price
- PULM N/A
- KITT N/A
- AVG Volume (30 Days)
- PULM 34.2K
- KITT 1.2M
- Earning Date
- PULM 08-12-2025
- KITT 08-12-2025
- Dividend Yield
- PULM N/A
- KITT N/A
- EPS Growth
- PULM N/A
- KITT N/A
- EPS
- PULM N/A
- KITT N/A
- Revenue
- PULM $1,921,000.00
- KITT $1,508,374.00
- Revenue This Year
- PULM N/A
- KITT $2,936.06
- Revenue Next Year
- PULM $134.88
- KITT N/A
- P/E Ratio
- PULM N/A
- KITT N/A
- Revenue Growth
- PULM N/A
- KITT N/A
- 52 Week Low
- PULM $1.78
- KITT $0.82
- 52 Week High
- PULM $10.40
- KITT $6.13
- Technical
- Relative Strength Index (RSI)
- PULM 49.28
- KITT 47.07
- Support Level
- PULM $8.49
- KITT $0.93
- Resistance Level
- PULM $8.75
- KITT $1.10
- Average True Range (ATR)
- PULM 0.42
- KITT 0.08
- MACD
- PULM -0.14
- KITT -0.00
- Stochastic Oscillator
- PULM 0.11
- KITT 29.41
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.